...
首页> 外文期刊>Oncogene >Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer
【24h】

Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer

机译:雄激素受体和microRNA-21轴下调前列腺癌中转化生长因子β受体II(TGFBR2)的表达

获取原文
           

摘要

Prostate cancer cells escape growth inhibition from transforming growth factor 尾 (TGF尾) by downregulating TGF尾 receptors. However, the mechanism by which cancer cells downregulate TGF尾 receptors in prostate is not clear. Here, we showed that coordinated action of miR-21 and androgen receptor (AR) signaling had a critical role in inhibiting TGF尾 receptor II (TGFBR2) expression in prostate cancer cells. Our results revealed that miR-21 suppresses TGFBR2 levels by binding to its 3鈥?UTR and AR signaling further potentiates this effect in both untransformed and transformed human prostate epithelial cells as well as in human prostate cancers. Analysis of primary prostate cancers showed that increased miR-21/AR expression parallel a significantly reduced expression of TGFBR2. Manipulation of androgen signaling or the expression levels of AR or miR-21 negatively altered TGFBR2 expression in untransformed and transformed human prostate epithelial cells, human prostate cancer xenografts and mouse prostate glands. Importantly, we demonstrated that miR-21 and AR regulated each other鈥檚 expression resulting in a positive feedback loop. Our results indicated that miR-21/AR mediate its tumor-promoting function by attenuating TGF尾-mediated Smad2/3 activation, cell growth inhibition, cell migration and apoptosis. Together, these results suggest that the AR and miR-21 axis exerts its oncogenic effects in prostate tumors by downregulating TGFBR2, hence inhibiting the tumor-suppressive activity of TGF尾 pathway. Targeting miR-21 alone or in combination with AR may restore the tumor inhibitory activity of TGF尾 in prostate cancer.
机译:前列腺癌细胞通过下调TGFβ受体而摆脱了转化生长因子β(TGFβ)的生长抑制。然而,癌细胞下调前列腺中TGFβ受体的机制尚不清楚。在这里,我们表明miR-21和雄激素受体(AR)信号的协同作用在抑制前列腺癌细胞中TGFβ受体II(TGFBR2)的表达中起着关键作用。我们的结果表明,miR-21通过与3'UTR结合而抑制TGFBR2的水平,AR信号转导在未转化和转化的人前列腺上皮细胞以及人前列腺癌中进一步增强了这种作用。对原发性前列腺癌的分析表明,增加的miR-21 / AR表达与TGFBR2的表达显着降低平行。在未转化和转化的人前列腺上皮细胞,人前列腺癌异种移植物和小鼠前列腺中,雄激素信号的操纵或AR或miR-21的表达水平使TGFBR2的表达负向改变。重要的是,我们证明了miR-21和AR相互调节表达,从而导致正反馈回路。我们的结果表明,miR-21 / AR通过减弱TGFβ介导的Smad2 / 3激活,细胞生长抑制,细胞迁移和凋亡来介导其肿瘤促进功能。总之,这些结果表明AR和miR-21轴通过下调TGFBR2而在前列腺肿瘤中发挥其致癌作用,从而抑制了TGFβ途径的肿瘤抑制活性。单独或与AR联合靶向miR-21可恢复TGFβ在前列腺癌中的肿瘤抑制活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号